Synchronized Phase‐Transition‐Induced Co‐Assembly of Short Peptide and Dexmedetomidine for Efficient Drug Encapsulation and Slow Release
Chemistry – A European Journal · 23.06.2026 · 32 (24)
DOI: 10.1002/chem.202503614 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, online erschienen am 10.04.2026. Verfasst von Xiaoyu Xie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Dexmedetomidine, Peptides. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Natural Science Foundation of Sichuan Province, Chengdu Municipal Science and Technology Program.
Abstract (Originalsprache)
Dexmedetomidine has been widely used clinically for perioperative sedation and analgesia, accompanied by the shortcomings of cardiovascular adverse effects and short duration. Although developing a slow‐releasing dexmedetomidine formulation is a conventional strategy to address these problems, it is unfortunately limited by the small molecule and high solubility of the drug. In this study, we designed a self‐assembling peptide (SAP) by referring to the chemical structure of dexmedetomidine, which contains a pH‐responsive imidazole group and a hydrophobic benzene group. By also containing the two groups, the peptide could simultaneously undergo pH‐induced phase‐transition together with dexmedetomidine, leading to their co‐assembly to form drug–peptide complexes. Different from well‐ordered nanofibers formed by the peptide alone, the co‐assembly system formed nanoparticles with relatively disordered core structures like biomolecular condensates. In this manner, the obtained formulation exhibited high drug encapsulation efficiency and a slow‐releasing profile, which further alleviated hypotension and extended the duration of sedative and analgesic efficacy in animal models. This study proposed a promising strategy to design SAPs for drug delivery in a personalized way. It also provided the slow‐releasing dexmedetomidine formulation as a promising candidate for clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China.
- Laboratory of Anesthesia and Critical Care Medicine, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China.
ORCID-Profile: Feng Qiu
Förderung
- Natural Science Foundation of Sichuan Province
- Chengdu Municipal Science and Technology Program
Zitieren
APA
Xie, X., Liu, J., Peng, F., Liu, C., Li, Y., Gong, D., Zhao, G., Qiu, F., & Zhang, W. (2026). Synchronized Phase‐Transition‐Induced Co‐Assembly of Short Peptide and Dexmedetomidine for Efficient Drug Encapsulation and Slow Release. Chemistry – A European Journal, 32(24). https://doi.org/10.1002/chem.202503614
Vancouver
Xie X, Liu J, Peng F, Liu C, Li Y, Gong D, et al. Synchronized Phase‐Transition‐Induced Co‐Assembly of Short Peptide and Dexmedetomidine for Efficient Drug Encapsulation and Slow Release. Chemistry – A European Journal. 2026;32(24). doi:10.1002/chem.202503614
BibTeX
@article{Xie2026,
author = {Xie, Xiaoyu and Liu, Jing and Peng, Fei and Liu, Congyan and Li, Yuncheng and Gong, Deying and Zhao, Guoyan and Qiu, Feng and Zhang, Wensheng},
title = {Synchronized Phase‐Transition‐Induced Co‐Assembly of Short Peptide and Dexmedetomidine for Efficient Drug Encapsulation and Slow Release},
journal = {Chemistry – A European Journal},
year = {2026},
volume = {32},
number = {24},
doi = {10.1002/chem.202503614}
}
EUVIMED